|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 334.20 CHF | +0.78% |
|
-0.71% | +1.83% |
| 15/07 | Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns | MT |
| 15/07 | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 341.5 | 374 | 367.8 |
| Spread/Res. | -2.14% | -10.64% | -9.14% |
| Spread/Supp. | +4.90% | +11.07% | +35.63% |
| Support | 318.6 | 300.9 | 246.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ROP Stock
- Charts Roche Holding AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition